AZSTARYS

Peak

serdexmethylphenidate and dexmethylphenidate

NDAORALCAPSULE
Approved
Mar 2021
Lifecycle
Peak
Competitive Pressure
0/100

Mechanism of Action

dexmethylphenidate. Dexmethylphenidate HCl is a central nervous system (CNS) stimulant. The mode of therapeutic action in ADHD is not known.

Indications (2)

Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of ageolder

Loss of Exclusivity

LOE Date
Dec 9, 2037
143 months away
Patent Expiry
Dec 9, 2037
Exclusivity Expiry
May 7, 2026

Patent Records (5)

Patent #ExpiryTypeUse Code
9079928
Jul 27, 2032
Product
—
10584112
Dec 9, 2037
SubstanceProduct
—
10584113
Dec 9, 2037
Product
—
10759778
Dec 9, 2037
Product
—
10858341
Dec 9, 2037
U-3094
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers